Contraceptive Devices Market Size, Share, Growth Analysis, By Product Type, By Technology, By Distribution Channel, By Region - Industry Forecast 2024-2031
Global Contraceptive Devices Market size was valued at USD 11.41 billion in 2022 and is poised to grow from USD 12.03 billion in 2023 to USD 18.32 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).
Market growth in the contraceptive sector is anticipated through programs aimed at reducing unintended pregnancies and healthcare costs while enhancing user awareness. Key initiatives such as Every Woman Every Child, Millennium Development Goals, and the 2030 Sustainable Development Goals (SDGs) are being spearheaded by governments and healthcare organizations to advocate for family planning and contraceptive utilization. Both private and public sectors significantly contribute to contraceptive provision, with the private sector predominantly supplying short-acting methods like condoms and pills. For instance, in Asia, around 41% of women source contraceptives privately, while 56% rely on public providers. Governments are also implementing extensive campaigns and sex education programs to promote contraceptive use among youth, receiving support from organizations like the WHO and CDC in fostering safe sex practices.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Contraceptive Devices Market Segmental Analysis
Global Contraceptive Devices Market is segmented by product type, technology, distribution channel and region. Based on product type, the market is segmented into male contraceptive devices, female contraceptive devices, female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants and others. Based on technology, the market is segmented into hormonal contraceptives and barrier contraceptives. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, clinics, online channels, public channel & ngo and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Contraceptive Devices Market
The Global Contraceptive Devices market is significantly driven by the introduction of highly efficient, non-hormonal intrauterine devices (IUDs). This innovative contraceptive technology presents a reliable and long-lasting option for women, combining a unique design that prioritizes safety and ease of use. The non-hormonal aspect reduces the likelihood of side effects, making it an attractive alternative for those who may be sensitive to hormonal contraception. Its effectiveness and user-friendly features cater to women's needs for convenience and dependability in birth control, thus enhancing its appeal in the market and potentially boosting overall demand for contraceptive solutions globally.
Restraints in the Global Contraceptive Devices Market
The Global Contraceptive Devices market faces certain constraints, particularly concerning the heightened risk of infections associated with the use of these devices. While contraceptive devices are designed to empower individuals in making informed reproductive health choices, the potential for infections can undermine their effectiveness and safety. The reliance on various methods, such as condoms, intrauterine devices (IUDs), and hormonal implants, is intended to provide reliable birth control and promote reproductive autonomy. However, concerns surrounding hygiene and the risks of complications can deter some users, hindering the broader acceptance and implementation of these essential tools for family planning and responsible sexual health practices.
Market Trends of the Global Contraceptive Devices Market
The Global Contraceptive Devices market is experiencing robust growth, driven by escalating rates of unwanted pregnancies and a heightened awareness of family planning methods. The rising incidence of sexually transmitted infections (STIs) and increased government funding for family planning initiatives further bolster market expansion. An array of contraceptive options including condoms, intrauterine devices, oral contraceptives, and subdermal implants, combined with growing consumer purchasing power, are notable contributors. Additionally, the surge in e-commerce, advancements in long-acting reversible contraceptives, and a trend towards innovative products align with the demand for non-hormonal and female-controlled contraceptives, thereby fueling continued market development.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Case Study Analysis
Startup Analysis
Global Contraceptive Devices Market Size by Product Type & CAGR (2024-2031)
Market Overview
Male Contraceptive Devices
Female Contraceptive Devices
Female Condoms, Diaphragms & Sponges
Vaginal Rings
Intrauterine Devices
Sub-Dermal Implants
Others
Global Contraceptive Devices Market Size by Technology & CAGR (2024-2031)
Market Overview
Hormonal Contraceptives
Barrier Contraceptives
Global Contraceptive Devices Market Size by Distribution Channel & CAGR (2024-2031)
Market Overview
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channel & Ngo
Others
Global Contraceptive Devices Market Size & CAGR (2024-2031)
North America (Product Type, Technology, Distribution Channel)
USA
Canada
Europe (Product Type, Technology, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Technology, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Technology, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Technology, Distribution Channel)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
Bayer AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Janssen Global Services, LLC (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merck Sharp & Dohme Corp. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Mylan N.V. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Reckitt Benckiser Group plc. (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Veru Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medisafe Distribution Inc. (Canada)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
CooperSurgical, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Devex (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Mayer Laboratories, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Allergan plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Agile Therapeutics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
HLL Lifecare (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Ansell Ltd (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Mankind Pharma (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
TTK HealthCare (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boehringer Ingelheim International GmbH. (Germany)